Ariadna Laguna

2.0k total citations · 1 hit paper
22 papers, 1.4k citations indexed

About

Ariadna Laguna is a scholar working on Molecular Biology, Neurology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Ariadna Laguna has authored 22 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 10 papers in Neurology and 5 papers in Cellular and Molecular Neuroscience. Recurrent topics in Ariadna Laguna's work include Parkinson's Disease Mechanisms and Treatments (9 papers), Down syndrome and intellectual disability research (5 papers) and Lysosomal Storage Disorders Research (4 papers). Ariadna Laguna is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (9 papers), Down syndrome and intellectual disability research (5 papers) and Lysosomal Storage Disorders Research (4 papers). Ariadna Laguna collaborates with scholars based in Spain, Sweden and France. Ariadna Laguna's co-authors include Susana de la Luna, Sergi Aranda, Thomas Perlmann, Bengt Mattsson, Anders Björklund, Banafsheh Kadkhodaei, Mickaël Decressac, Miquel Vila, María L. Arbonés and Núria Peñuelas and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Nature Neuroscience.

In The Last Decade

Ariadna Laguna

21 papers receiving 1.4k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Human Microglia Atlas (HuMicA) unravels changes in disease-associated microglia subsets across neurodegenerative conditions

2025 21 citations Josep Calafell-Segura, Bárbara Leal et al. Nature Communications profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ariadna Laguna Spain	16	682	426	348	221	195	22	1.4k
Pike-See Cheah Malaysia	24	924 1.4×	153 0.4×	102 0.3×	128 0.6×	70 0.4×	87	1.8k
Fiorella Malchiodi‐Albedi Italy	26	875 1.3×	343 0.8×	157 0.5×	86 0.4×	180 0.9×	61	1.8k
Yunhee Kim Kwon South Korea	28	912 1.3×	386 0.9×	77 0.2×	90 0.4×	92 0.5×	72	1.8k
Claudia Crosio Italy	22	1.6k 2.4×	341 0.8×	682 2.0×	80 0.4×	570 2.9×	36	2.7k
Elena Fontana Italy	20	600 0.9×	160 0.4×	319 0.9×	41 0.2×	187 1.0×	37	1.7k
Tomohiro Kabuta Japan	26	1.1k 1.7×	245 0.6×	625 1.8×	59 0.3×	401 2.1×	55	2.2k
Dianshuai Gao China	25	856 1.3×	418 1.0×	189 0.5×	34 0.2×	89 0.5×	125	1.8k
Eva Teuling Netherlands	12	462 0.7×	274 0.6×	444 1.3×	59 0.3×	237 1.2×	14	1.1k
Saki Shimizu Japan	29	810 1.2×	708 1.7×	247 0.7×	28 0.1×	72 0.4×	91	2.0k
Fulvio Celsi Italy	17	689 1.0×	389 0.9×	467 1.3×	38 0.2×	177 0.9×	49	1.6k

Countries citing papers authored by Ariadna Laguna

Since Specialization

Citations

This map shows the geographic impact of Ariadna Laguna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ariadna Laguna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ariadna Laguna more than expected).

Fields of papers citing papers by Ariadna Laguna

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ariadna Laguna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ariadna Laguna. The network helps show where Ariadna Laguna may publish in the future.

Co-authorship network of co-authors of Ariadna Laguna

This figure shows the co-authorship network connecting the top 25 collaborators of Ariadna Laguna. A scholar is included among the top collaborators of Ariadna Laguna based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ariadna Laguna. Ariadna Laguna is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Calafell-Segura, Josep, Bárbara Leal, Javier Rodríguez‐Ubreva, et al.. (2025). The Human Microglia Atlas (HuMicA) unravels changes in disease-associated microglia subsets across neurodegenerative conditions. Nature Communications. 16(1). 739–739. 21 indexed citations breakdown →

Laguna, Ariadna, Núria Peñuelas, Marta González-Sepúlveda, et al.. (2024). Modelling human neuronal catecholaminergic pigmentation in rodents recapitulates age-related neurodegenerative deficits. Nature Communications. 15(1). 8819–8819. 8 indexed citations

Hernández‐Vara, Jorge, et al.. (2024). Evaluation of a Liquid Chromatography–Tandem Mass Spectrometry Method for the Analysis of Glucosylceramide and Galactosylceramide Isoforms in Cerebrospinal Fluid of Parkinson’s Disease Patients. Analytical Chemistry. 96(31). 12875–12882. 6 indexed citations

Lerche, Stefanie, Isabel Wurster, Enza Maria Valente, et al.. (2024). CSF d18:1 sphingolipid species in Parkinson disease and dementia with Lewy bodies with and without GBA1 variants. npj Parkinson s Disease. 10(1). 198–198.

Deus, Cláudia M., Mercè Avellanet, Ariadna Laguna, et al.. (2023). Investigating the impact of physical activity on mitochondrial function in Parkinson’s disease (PARKEX): Study protocol for A randomized controlled clinical trial. PLoS ONE. 18(11). e0293774–e0293774. 4 indexed citations

González-Sepúlveda, Marta, Joan Compte, Thaïs Cuadros, et al.. (2022). In vivo reduction of age-dependent neuromelanin accumulation mitigates features of Parkinson’s disease. Brain. 146(3). 1040–1052. 17 indexed citations

Laguna, Ariadna, Helena Xicoy, Eduardo Tolosa, et al.. (2021). Serum metabolic biomarkers for synucleinopathy conversion in isolated REM sleep behavior disorder. npj Parkinson s Disease. 7(1). 40–40. 11 indexed citations

González-Sepúlveda, Marta, Ariadna Laguna, Iria Carballo‐Carbajal, et al.. (2020). Validation of a Reversed Phase UPLC-MS/MS Method to Determine Dopamine Metabolites and Oxidation Intermediates in Neuronal Differentiated SH-SY5Y Cells and Brain Tissue. ACS Chemical Neuroscience. 11(17). 2679–2687. 12 indexed citations

Carballo‐Carbajal, Iria, Ariadna Laguna, Jordi Romero‐Giménez, et al.. (2019). Brain tyrosinase overexpression implicates age-dependent neuromelanin production in Parkinson’s disease pathogenesis. Nature Communications. 10(1). 973–973. 234 indexed citations

10.

Xicoy, Helena, Núria Peñuelas, Miquel Vila, & Ariadna Laguna. (2019). Autophagic- and Lysosomal-Related Biomarkers for Parkinson’s Disease: Lights and Shadows. Cells. 8(11). 1317–1317. 27 indexed citations

11.

Lassot, Irina, Suzanne Lesage, Barbara A. Zieba, et al.. (2018). The E3 Ubiquitin Ligases TRIM17 and TRIM41 Modulate α-Synuclein Expression by Regulating ZSCAN21. Cell Reports. 25(9). 2484–2496.e9. 30 indexed citations

12.

Doucet-Beaupré, Hélène, Consiglia Pacelli, Nicolas Giguère, et al.. (2016). Lmx1a and Lmx1b regulate mitochondrial functions and survival of adult midbrain dopaminergic neurons. Proceedings of the National Academy of Sciences. 113(30). E4387–96. 64 indexed citations

13.

Laguna, Ariadna, Nicoletta Schintu, André Nobre, et al.. (2015). Dopaminergic control of autophagic-lysosomal function implicates Lmx1b in Parkinson's disease. Nature Neuroscience. 18(6). 826–835. 64 indexed citations

14.

Barallobre, Marı́a José, Céline Perier, Jordi Bové, et al.. (2014). DYRK1A promotes dopaminergic neuron survival in the developing brain and in a mouse model of Parkinson’s disease. Cell Death and Disease. 5(6). e1289–e1289. 34 indexed citations

15.

Panman, Lia, Maria Papathanou, Ariadna Laguna, et al.. (2014). Sox6 and Otx2 Control the Specification of Substantia Nigra and Ventral Tegmental Area Dopamine Neurons. Cell Reports. 8(4). 1018–1025. 112 indexed citations

16.

Laguna, Ariadna, Marı́a José Barallobre, Miguel Marchena, et al.. (2013). Triplication of DYRK1A causes retinal structural and functional alterations in Down syndrome. Human Molecular Genetics. 22(14). 2775–2784. 41 indexed citations

17.

Decressac, Mickaël, Banafsheh Kadkhodaei, Bengt Mattsson, et al.. (2012). α-Synuclein–Induced Down-Regulation of Nurr1 Disrupts GDNF Signaling in Nigral Dopamine Neurons. Science Translational Medicine. 4(163). 163ra156–163ra156. 220 indexed citations

18.

Ferrón, Sacri R., Ariadna Laguna, Sergi Aranda, et al.. (2010). Regulated Segregation of Kinase Dyrk1A during Asymmetric Neural Stem Cell Division Is Critical for EGFR-Mediated Biased Signaling. Cell stem cell. 7(3). 367–379. 61 indexed citations

19.

Laguna, Ariadna, Sergi Aranda, Marı́a José Barallobre, et al.. (2008). The Protein Kinase DYRK1A Regulates Caspase-9-Mediated Apoptosis during Retina Development. Developmental Cell. 15(6). 841–853. 102 indexed citations

20.

Aranda, Sergi, et al.. (2008). Sprouty2-Mediated Inhibition of Fibroblast Growth Factor Signaling Is Modulated by the Protein Kinase DYRK1A. Molecular and Cellular Biology. 28(19). 5899–5911. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact